Compare Mutual Funds

Pros
3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Generated Consistent Returns.

Generated Consistent Returns.

Consistently beats benchmark.

Consistently beats benchmark.

Lower probablity of downside risk.

Lower probablity of downside risk.

Cons

-

-

INDMoney rank
-
1/21
Category

Equity, Mid-Cap

Equity, Mid-Cap

Fund Age

5 Years 1 Months

13 Years 5 Months

Fund AUM

₹1325 Cr

₹94257 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹100
Expense Ratio

0.28%

0.76%

Exit Load

0.5%

1%

Benchmark Index

Nifty Midcap 150 TR INR

Nifty Midcap 150 TR INR

No of Holdings

83

80

Top 5 Holdings
  1. The Federal Bank Ltd(2.98%)
  2. Sundaram Finance Ltd(1.98%)
  3. IndusInd Bank Ltd(1.93%)
  4. Solar Industries India Ltd(1.91%)
  5. Fortis Healthcare Ltd(1.91%)
  1. Max Financial Services Ltd(4.96%)
  2. The Federal Bank Ltd(4.07%)
  3. AU Small Finance Bank Ltd(4%)
  4. Indian Bank(3.87%)
  5. Balkrishna Industries Ltd(3.38%)
No of Sectors

13

10

Top 3 Sectors
  1. Financial Services(27.11%)
  2. Industrial(23.23%)
  3. Basic Materials(11.58%)
  1. Financial Services(30.43%)
  2. Consumer Cyclical(17.46%)
  3. Health(14.43%)
Equity %

96.13%

94.23%

Debt %

0.23%

-

P/E

20.22

25.6

P/B

3.92

3.57

Credit Quality

-

-

Modified Duration

1.04

-

YTM

6.37

-

1-Month Return

-7.38%

-8.09%

3-Month Return

-8.34%

-7.12%

6-Month Return

-2.65%

-2.69%

1-Year Return

6.34%

8.49%

3-Year Return

25.2%

25.05%

5-Year Return

17.68%

22.33%

Sharpe

1.18

1.39

Alpha

1.9

4.28

Beta

1

0.85

Standard Deviation

16.2

13.69

Information Ratio

0.51

0.66

Description

ITI Mid Cap Fund is an equity fund.The fund could potentially beat inflation in the long-run.

HDFC Mid Cap Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Dhimant Shah, Rohan Korde

Dhruv Muchhal, Chirag Setalvad

Most Popular Comparisons